Cargando…
Targeting adenosinergic pathway and adenosine A(2A) receptor signaling for the treatment of COVID-19: A hypothesis
The most serious health issue today is the rapid outbreak of Coronavirus Disease 2019 (COVID-19). More than 6,973,427 confirmed cases were diagnosed in nearly 213 countries and territories around the world and two international conveyances, causing globally over 400,000 deaths. Epidemiology, risk fa...
Autor principal: | Abouelkhair, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303042/ https://www.ncbi.nlm.nih.gov/pubmed/32590324 http://dx.doi.org/10.1016/j.mehy.2020.110012 |
Ejemplares similares
-
The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022) -
Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma
por: Jin, Ketao, et al.
Publicado: (2021) -
Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases
por: Faraoni, Erika Y., et al.
Publicado: (2022) -
The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
por: Cellai, Lucrezia, et al.
Publicado: (2018)